Cells use a combination of changes in adhesion, proteolysis and motility (directed and random) during the process of migration. Proteolysis of the extracellular matrix (ECM) results in the creation of haptotactic gradients, which cells use to move in a directed fashion. The proteolytic creation of these gradients also results in the production of digested fragments of ECM. In this study we show that in the human ¢brosarcoma cell line HT1080, matrix metalloproteinase-2(MMP-2)-digested fragments of ¢bronectin exert a chemotactic pull stronger than that of undigested ¢bronectin. During invasion, this gradient of ECM fragments is established in the wake of an invading cell, running counter to the direction of invasion. The resultant chemotactic pull is anti-invasive, contrary to the traditional view of the role of chemotaxis in invasion. Uncontrolled ECM degradation by high concentrations of MMP can thus result in steep gradients of ECM fragments, which run against the direction of invasion. Consequently, the invasive potential of a cell depends on MMP production in a biphasic manner, implying that MMP inhibitors will upregulate invasion in high-MMP-expressing cells. Hence the therapeutic use of protease inhibitors against tumours expressing high levels of MMP could produce an augmentation of invasion.
INTRODUCTION
The migration of cells, a fundamental process in health and disease, is seen in a large number of settings, such as in£ammation, metastasis and placentation. A critical feature of cell migration is the ability of the migratory cells to digest extracellular matrix (ECM) as they move through it, by secreting enzymes such as matrix metalloproteases (MMPs). Invasive cells in vivo adhere to surrounding ECM molecules via speci¢c receptors such as integrins, and respond to signals transduced by this interaction, together with cytokine and growth-factor signals, to produce and secrete MMPs and other proteases (Seftor et al. 1992) . The consequent digestion of the ECM allows the cells to move into the spaces thereby created and also sets up a positive gradient, which the cells then exploit to move forwards. Movement up concentration gradients of ECM has been previously reported as a mechanism enabling movement through tissues of a variety of cell types, including neutrophils in in£ammation, malignant cells during metastasis, and trophoblasts during placentation (Hynes 1994) .
The term chemotaxis is used to describe cell motility in response to a gradient of a soluble attractant. In contrast, haptotaxis denotes motility towards insoluble, substratumbound attractants such as laminin and ¢bronectin. The di¡erences between chemotaxis and haptotaxis have been highlighted by the demonstration that separate domains on the NH 2 -and COOH-terminal regions of the thrombospondin molecule are responsible for chemotaxis and haptotaxis, respectively, and that the two processes can be di¡erentially inhibited by antibodies to the relevant sites (Taraboletti et al. 1987) . Further studies have shown that chemotaxis to type-IV collagen was profoundly inhibited by pertussis toxin treatment in A2058 cells, whereas haptotaxis remained largely una¡ected (Aznavoorian et al. 1990 ). The insensitivity of haptotaxis to pertussis toxin suggests that chemotaxis and haptotaxis are induced by distinct transduction mechanisms. The signi¢cance of haptotactic migration is apparent when considering that, during the process of tumour invasion and metastasis, proteolytic degradation of ¢xed ECM proteins results in the creation of gradients, which the cells can use to invade in a directed fashion (Liotta 1986 ). However, this digestion also generates soluble ECM fragments, in the wake of the invading cells, whose role has not previously been considered.
In this paper, we consider the way in which chemotaxis and haptotaxis conspire to regulate invasion. In ½ 2, we present experimental evidence indicating that both processes are signi¢cant for one particular cell^matrix system. Building on these observations, we then (½ 3) develop a mathematical model for the invasive process in one space dimension. In ½ 4, we return to our experimental system to test the predictions of the mathematical model.
CHEMOTACTIC EFFECTS OF DIGESTED FIBRONECTIN
To test the potential for products of ECM degradation to a¡ect cell movement, we used HT1080 cells in a standard dual-chamber chemotaxis assay (Aznavoorian et al. 1990) . In these assays, two compartments, one containing the cells and the other containing the chemoattractant, are separated by a polycarbonate ¢lter with a uniform pore size, which is smaller than the diameter of the cells. As a chemotactic gradient is established across the ¢lter the cells migrate from the upper to the lower compartment. Several cells (e.g. neutrophils (Springer 1990 ) and A2058 (Melchiori et al. 1995) ) have previously been shown to respond to chemotactic stimulation in such dual-chamber chemotaxis assays. Our studies were conducted with HT1080 cells, a rapidly proliferating human ¢brosarcoma cell line that has been shown to respond chemotactically to ECM gradients of type-IV collagen and ¢bronectin (Aznavoorian et al. 1990 ). We used ¢bronectin as our chemotactic substrate because previous checkerboard analysis has shown that in the presence of ¢bronectin HT1080 cells predominantly show directed motility with minimal interference from chemokinetic movement (Aznavoorian et al. 1990) . The HT1080 cells bind to ¢bronectin through speci¢c receptors, which can be blocked by monoclonal antibodies against the a 5 domain of integrins (Deryugina et al. 1996) . In our experiments we compared the migratory response of HT1080 cells to intact and MMP-2-digested ¢bronectin. The digestion of ¢bronectin by MMP-2 produced fragments of di¡erent sizes when seen on SDS^PAGE.
These ¢bronectin fragments pooled together were strongly chemotactic, with chemotactic potency increased by digestion with moderate levels of MMP-2 (50 mg ml 71 ) (¢gure 1). The peak migratory response was seen at a ¢bronectin concentration of 20 mg ml
71
, with a further increase in concentration producing a decreased response, probably because of the saturation of receptors. Other instances of the proteolytic augmentation of ECMmediated e¡ects have recently been reported for laminin-5 in breast epithelial cell migration (Giannelli et al. 1997) and type-IV collagen in angiogenesis (Sage 1997) . Our initial ¢nding raised the possibility that gradients of soluble ECM fragments may be acting in concert with gradients of intact ECM during cellular invasion. The latter type of directed movement on intact matrix components is haptotactic, and has been described in a number of previous studies (Aznavoorian et al. 1990; Klominek et al. 1993) ; in contrast, the response to the soluble fragments is chemotactic.
To explore the way in which these di¡erent motility mechanisms might interact, we constructed a mathematical model to simulate a cellular invasion.
MATHEMATICAL MODEL
We denote the concentrations of the HT1080 cells, intact ¢bronectin, MMP-2, and the MMP-2-digested soluble ¢bronectin by u(x,t), c(x,t), p(x,t) and s(x,t), respectively; t and x represent time and space in a onedimensional spatial domain. The equations are of conservation type (Murray 1990) :
solubilized fibronectin:
MMP-2: dp dt Chemotaxis was assayed in duplicate by using 24-well chemotaxis dual chambers (Falcon) as previously described (Aznavoorian et al. 1990) . Brie£y, ¢lters were precoated with type-IV collagen (Sigma) (10 mg ml 71 in 0.1 M acetic acid) to enhance cell adherence. The chemoattractants (intact and MMP-2-digested ¢bronectin (Sigma)), dissolved in DMEM with 0.1% BSA, were added to separate lower wells in the indicated concentrations; the upper wells received 10 5 HT1080 cells (ATCC CCL-121) in 200 ml of DMEM with 0.1% BSA(GIBCO-BRL). The MMP-2 was a gift from British Biotech, Oxford, UK. The chambers were incubated at 37 8C with 5% CO 2 for 4 h. Filters were then processed and migration quantitated by averaging migrated cell counts in nine high-power ¢elds (Â40). The functions 1(c) and 2(s) (discussed in ½ 3), which represent the modulation of chemotaxis and haptotaxis, were extracted from the data as 1(c) À0X074c 2 14X65c 102X1 and 2(s) À0X151s 2 24X9s 146X6 by using a least-squares quadratic ¢t.
Here the k i s are positive constants. The functions 2(s) and 1(c) re£ect the extent of chemotaxis and haptotaxis; we determined their functional forms from the data in ¢gure 1, giving the forms listed in the ¢gure legend. The proteolysis of ¢bronectin is represented by Àpc; the resultant solubilized ¢bronectin di¡uses in space and the intact ¢bronectin is anchored in place. The term h( p,s) represents continued action of proteases, whereby ¢bro-nectin fragments are themselves broken down to give smaller fragments. This is a key term in the model, which we discuss in detail below. Our representation of the production of MMP-2 by the term uc re£ects the fact that protease production in vivo is tightly con¢ned to the immediate pericellular environment (Werb 1997; Xie et al. 1994) through signals transduced by the interaction of ECM with speci¢c cellular receptors.
We studied numerical simulations of this model for a wide range of parameter values, with initial conditions corresponding to a localized cell population surrounded by intact ¢bronectin. In all cases the solutions evolve to travelling wave fronts moving in the positive x-direction, corresponding to invading waves of cells and receding waves of ECM, with a pulse wave of MMP-2 localized at the interface between these fronts. The common speed of these waves provides a convenient measure of the invasiveness of the cell population. In all cases, the model predicts that invasiveness decreases as the chemotactic coe¤cient k 3 is increased (¢gure 2a). This implies that ECM chemotaxis actually inhibits invasion, contrary to its conception as a pro-invasive factor; this is because the gradient in degraded soluble ECM (s) is in the opposite direction to invasion. The predictions of the model depend crucially on the function h( p,s), which represents the possibility of repeated breakdown of ECM fragments by proteases. If this term is excluded from the model, the invasiveness of the cell population increases continuously with increasing protease production (k 3 ) (¢gure 2b). However, with h( p,s) included, the model predicts a decrease in invasiveness at high rates of protease production (¢gure 2b). To test the biological validity of the term h( p,s) within the mathematical model, we digested ¢bro-nectin (1mg ml 71 ) with MMP-2 (50 mg ml
71
) for various times (0^16 h) and analysed the products on SDS^PAGE. This showed a progressive digestion of ¢bronectin-yielding fragments with smaller molecular mass with increasing incubation time (¢gure 3a). The progressive nature of this reaction con¢rms the validity of the term h( p,s).
The prediction of low invasiveness at high rates of MMP production is consistent with the previous observations that cells producing extremely large amounts of serine proteases actually become non-invasive. In these experiments it was shown that the invasive behaviour in vitro of cells that produce large amounts of tissue plasminogen activator, or urokinase-type plasminogen activator, is not blocked but enhanced by the addition of plasmin inhibitors or anti-plasmin antibodies (Tsuboi & Rifkin 1990) . Conversely, the invasive capacity of cells that produce low levels of these proteases was blocked by the addition of inhibitors. Protease activity in excess of an optimal level producing uncontrolled matrix degradation produces non-invasion. Similar studies with endothelial cells Pepper et al. 1990 ) also show that successful angiogenesis requires an optimal level of protease expression. A suggestion has been made (StetlerStevenson et al. 1993 ) that this may be a consequence of the uncontrolled breakdown of matrix, marooning the cells without an underlying matrix to crawl on, and thereby abolishing haptotaxis (i.e. dcadx 0). However, this explanation assumes that the time-scales of ECM proteolysis and cell movement are widely di¡erent and that they occur sequentially, both of which are contrary to the prevailing view (Stetler-Stevenson et al. 1993; Lau¡enburger 1996) . The functions 1(c) and 2(s) were derived from the data in ¢gure 1. For all the parameter sets we investigated, the invasiveness falls with increasing chemotactic sensitivity. (b) The dependence of the invasion speed (normalized) on MMP-2 production with and without h( p,s). When`dynamic chemotactic drag' is neglected (i.e. h( p,s) 0), invasiveness increases continuously with MMP-2 expression. However, when the dynamic chemotactic drag due to continued ¢bronectin degradation (shown in ¢gure 3) is considered, invasiveness is parabolically related to MMP-2 expression.
The parameter values used in these simulations are k 1 1X0, Our model predicts that invasion occurs via a cell being sandwiched between two competing gradients, namely a pro-invasive haptotactic gradient of ¢xed ECM and an anti-invasive chemotactic gradient of soluble ECM fragments (¢gure 3b). Both of these gradients are produced dynamically as the invasion proceeds; and we refer to this soluble gradient as providing a`dynamic chemotactic drag', which counteracts the invasive process.
COMPETING GRADIENTS OF DIGESTED AND UNDIGESTED FIBRONECTIN
To test these predictions, we investigated the movement of HT1080 cells under competing gradients of intact and digested ¢bronectin. We again used a standard dualchamber chemotaxis assay; however, in this case ¢bro-nectin was placed in both the upper and lower wells. The addition of putative chemoattractant to both wells of a chemotaxis assay is an established technique, forming the basis for the method of`checkerboard analysis' used to distinguish between chemotaxis and chemokinesis (Aznavoorian et al. 1990 ). In our experiments, we adapted this approach by using intact ¢bronectin in the lower well, and digested ¢bronectin in the upper well; the digested ¢bronectin is generated by preincubation with MMP-2, as in the experiments described in ½ 2. This new experimental scenario means that the cell population is situated in opposing gradients of intact and digested ECM, mimicking the situation in vivo predicted by our mathematical model. As predicted by the mathematical model, the opposing gradients of intact and digested ¢bronectin retard cell migration in a dose-dependent fashion (¢gure 4). In particular, the diagonal elements in the array in ¢gure 4 represent competing gradients of equal concentrations of digested and undigested ¢bro-nectin, indicating conservation of ¢bronectin as would be seen in vivo. At low (equal) concentrations, the cells move preferentially towards the undigested ¢bronectin, but as the concentrations of both ¢bronectin types are increased, the number of migrating cells decreases dramatically and eventually the level of migration is reduced below that in controls. Thus the digested ¢bronectin fragments exert the predominant force, overriding the intact ¢bronectin. The increased chemotactic potency of MMP-2-digested ¢bronectin may be due to the exposure of cryptic promigratory sites or to the cumulative e¡ect of an increased number of proteolysed fragments that are separately chemotactic. An example of the former mechanism is the MMP-2 cleavage of laminin-5 g2 subunit at residue 587, which exposes a promigratory site that triggers cell motility (Giannelli et al. 1997) . The latter mechanism has been observed with Entamoeba histolytica trophozoites, where the 70 and 120 kDa fragments of the proteolytic digestion of ¢bronectin were found to be more chemotactic than intact ¢bronectin (Franco et al. 1997) . A similar paradoxical e¡ect of proteolysis is the anti-in£ammatory e¡ect of a trisulphated disaccharide ECM fragment derived by heparanase treatment (Lider et al. 1995) .
DISCUSSION
The prediction that ECM-mediated chemotaxis is an anti-invasive force runs counter to traditional views of invasion, which stem from the way in which chemotaxis is usually studied, namely by using dual-chamber chemotaxis assays set up with the chemoattractant concentration gradient running in the same direction as that of overall cell movement. Our results suggest that, in practice, chemoattractant gradients are generated dynamically through ECM degradation during the invasion process, and that these run in the opposite sense, against the direction of invasion. These chemoattractant gradients may eventually become ¢xed by binding to other ECM proteins (Hynes 1994 ). This mechanism implies that an optimally invasive phenotype corresponds to a balance between protease production and inhibition, and the relative proportions of digested and intact ECM components. Uncontrolled proteolysis by large amounts of proteases would result in the establishment of steep chemotactic gradients in the wake of invasion, which would impede the outward invasive movement of the cells. Because these chemotactic gradients are soluble they would eventually be dissipated, resulting in continued invasion, albeit at a lower rate. In such cells, the addition of antiproteases such as TIMPs would attenuate the chemotactic drag and cause faster invasion, as has previously been reported for Bowes' melanoma cells (Tsuboi & Rifkin 1990) .
The motility-retarding e¡ects of ECM chemotaxis elucidated here have important implications for our understanding of cellular invasion processes in general and of the molecular approaches to anti-cancer therapeutics in particular. The demonstration that chemotaxis and haptotaxis operate through di¡erent receptors (Taraboletti et al. 1987) and have di¡erent signal transduction pathways (Aznavoorian et al. 1990 ) has presented the possibility of two separate targets to retard invasion. However, the results of this study would imply that speci¢cally targeting ECM-mediated chemotaxis could produce the opposite e¡ect, resulting in an augmentation of invasion. Furthermore, the reappraisal of chemotaxis presented here predicts that protease inhibitors can also produce an early increase of invasion in high-protease expressers in appropriate ECM-rich environments. The results of this study show that such unintended augmentation of invasion by antiproteases can be e¡ectively prevented by combining anti-protease therapy with haptotactic blockade. A large number of such potential protease inhibitors are currently in advanced stages of clinical and animal trials (Denis & Verweij 1997) . Although similar progress has not been made with haptotactic blockade, studies in vitro with speci¢c antibodies (Taraboletti et al. 1987) have been shown to be e¡ective. A combination of these two modalities would not only be naturally synergistic, resulting in faster remission, but would also prevent any early increase in invasion.
